期刊
NATURE REVIEWS CARDIOLOGY
卷 14, 期 1, 页码 39-55出版社
NATURE PORTFOLIO
DOI: 10.1038/nrcardio.2016.174
关键词
-
资金
- National Institute for Health Research (NIHR) Career Development Fellowship
- MRC Grant [G0500783]
- National Institute for Health Research Career Development Fellowship [CDF - 2012-05-231]
- MRC [G0500783] Funding Source: UKRI
- Medical Research Council [G0500783] Funding Source: researchfish
- National Institute for Health Research [CDF-2012-05-231] Funding Source: researchfish
- National Institutes of Health Research (NIHR) [CDF-2012-05-231] Funding Source: National Institutes of Health Research (NIHR)
Myocardial and vascular endothelial tissues have receptors for thyroid hormones and are sensitive to changes in the concentrations of circulating thyroid hormones. The importance of thyroid hormones in maintaining cardiovascular homeostasis can be deduced from clinical and experimental data showing that even subtle changes in thyroid hormone concentrations such as those observed in subclinical hypothyroidism or hyperthyroidism, and low triiodothyronine syndrome-adversely influence the cardiovascular system. Some potential mechanisms linking the two conditions are dyslipidaemia, endothelial dysfunction, blood pressure changes, and direct effects of thyroid hormones on the myocardium. Several interventional trials showed that treatment of subclinical thyroid diseases improves cardiovascular risk factors, which implies potential benefits for reducing cardiovascular events. Over the past 2 decades, accumulating evidence supports the association between abnormal thyroid function at the time of an acute myocardial infarction (MI) and subsequent adverse cardiovascular outcomes. Furthermore, experimental studies showed that thyroid hormones can have an important therapeutic role in reducing infarct size and improving myocardial function after acute MI. In this Review, we summarize the literature on thyroid function in cardiovascular diseases, both as a risk factor as well as in the setting of cardiovascular diseases such as heart failure or acute MI, and outline the effect of thyroid hormone replacement therapy for reducing the risk of cardiovascular disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据